chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Lymphadenopathy, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Severe joint and muscle pain.; Severe joint and muscle pain.; Sore arm were shot was administered; Sore and swollen lymph nodes in the right armpit; Sore and swollen lymph nodes in the right armpit; Low-moderate fever; Chills/shivers; Headache; Lethargy/exhaustion; Lethargy/exhaustion; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 29Apr2021 at 16:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), asthma, anxiety / depression, eczema and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included amfetamine aspartate / amfetamine sulfate / dexamfetamine saccharate / dexamfetamine sulfate (ADDERALL), intrauterine contraceptive device (MANUFACTURER UNKNOWN) and loratadine (CLARITIN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received bupropion (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy.  The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. On 30Apr2021 at 06:00, the patient had severe joint and muscle pain, sore arm where shot was administered, sore and swollen lymph nodes in the right armpit, low-moderate fever, chills/shivers, headache, lethargy and exhaustion. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe joint and muscle pain, sore arm where shot was administered, sore and swollen lymph nodes in the right armpit, low-moderate fever, chills/shivers, headache, lethargy and exhaustion was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site bruising
Clinical narrative: the needle site was bruised; felt exhausted; This is a spontaneous report received from Pfizer sponsor program reported from a non-contactable consumer (patient). A 27-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 03May2021 (at the age of 27-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on unspecified date (at the age of 27-years-old) as DOSE 1, SINGLE for covid-19 immunisation. On 05May2021, the day after get-ting second shot the patient felt exhausted and noted "the needle site was bruised". He considered these symptoms to be "Very mild". The outcome of the events unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: Extremely sore arm; Body aches; Headache; Tiredness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 29Apr2021 at 16:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 08Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021 at 02:00, the patient experienced extremely sore arm, body aches, headache, tiredness and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely sore arm, body aches, headache, tiredness and fatigue were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Approximately one week after vaccine, my existing tinnitus ramped up significantly and has not changed; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 16Mar2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos, graves, asthma, allergies, tinnitus and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included azelastine (MANUFACTURER UNKNOWN), fluticasone propionate (FLONASE), fexofenadine hydrochloride (ALLEGRA) and fluticasone propionate (FLOVENT); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received cefuroxime axetil (CEFTIN) on an unknown date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021, the patient experienced existing tinnitus ramped up significantly and had not changed (was still significantly more tinnitus than had before) and the patient could hear it over most noises now. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event existing tinnitus ramped up significantly and had not changed was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Head discomfort, Headache, Tinnitus
Clinical narrative: Dizzy/woozy; Heavy head pressure; Headache; High pitched ringing in right ear, off and on; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW969) via an unspecified route of administration in the left arm on 15Apr2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included fish oil (MANUFACTURER UNKNOWN), oenothera biennis oil (PRIMROSE OIL), calcium (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 10:00, the patient experienced dizzy, woozy, heavy head pressure, headache, constant high-pitched ringing in right ear (on and off) and extreme fatigue began the day after first vaccine and had continued ever since, the ear ringing had become more constant. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, dizzy, woozy, heavy head pressure, headache, constant high-pitched ringing in right ear (on and off) and extreme fatigue began the day after first vaccine and had continued ever since, the ear ringing had become more constant were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph nodes under left arm; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on an unknown date and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 28Apr2021(at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced swollen lymph nodes under left arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes under left arm was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Joint pain in both knees and both elbows; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 11Apr2021 at 14:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (BP), cholesterol and known allergies to non-steroidal anti-inflammatory drugs (NSAIDs). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 13Apr2021, the patient experienced joint pain in both knees and both elbows. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event joint pain in both knees and both elbows was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia, Vaccination site bruising, Vaccination site pain
Clinical narrative: Fever; Headache; Body aches; Pain, swelling, and bruising at injection site.; Pain, swelling, and bruising at injection site.; Pain, swelling, and bruising at injection site.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 27Apr2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease, gallbladder removed, tonsils, allergies and known allergies to sulfa drugs and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol/levonorgestrel (CAMRESE LO) and montelukast sodium (SINGULAIR); both from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 06Apr2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Apr2021 at 15:15, the patient experienced pain, swelling, and bruising at injection site. On 28Apr2021, the patient experienced fever, headache and body aches that began the next day and lasted until that night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain, swelling, and bruising at injection site was resolved on an unknown date in 2021; while that of the events fever, headache and body aches was resolved on 28Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Fever; Headache; Body aches; Pain, swelling, and bruising at injection site.; Pain, swelling, and bruising at injection site.; Pain, swelling, and bruising at injection site.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 27Apr2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease, gallbladder removed, tonsils, allergies and known allergies to sulfa drugs and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol/levonorgestrel (CAMRESE LO) and montelukast sodium (SINGULAIR); both from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 06Apr2021 at 15:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 27Apr2021 at 15:15, the patient experienced pain, swelling, and bruising at injection site. On 28Apr2021, the patient experienced fever, headache and body aches that began the next day and lasted until that night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain, swelling, and bruising at injection site was resolved on an unknown date in 2021; while that of the events fever, headache and body aches was resolved on 28Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Diarrhoea, Muscle strain, Musculoskeletal chest pain
Clinical narrative: On second day woke up with red rash on my face (no where else).; Next morning felt like every bone was broken in entire body; Acheyness started 6 hours after shot; 101 fever for 24 hours; On day 3 of diarrehea, violently threw up for 24 hours (pulled muscle in shoulder and sore ribs); On day 3 of diarrehea, violently threw up for 24 hours; Pulled muscle in shoulder and sore ribs; Pulled muscle in shoulder and sore ribs; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, polycystic ovarian syndrome (PCOS), allergy to intravenous pyelogram (IVP) dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); both from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient previously received azithromycin (Z-PAK) and codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 28Apr2021 at 17:00, 6 hours after shot the patient experienced acheyness. On 29Apr2021, next morning the patient felt like every bone was broken in entire body. On Apr2021, the patient experienced 101 fever for 24 hours, on day 3 of diarrhea, violently threw up for 24 hours (pulled muscle in shoulder and sore ribs). On 30Apr2021, on second day woke up with red rash on my face (no where else). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 101 (units unspecified) fever for 24 hours was resolved on Apr2021, while that of the event violently threw up for 24 hours was resolved on an unknown date in Apr2021. The clinical outcome of the events achiness started 6 hours after shot, next morning felt like every bone was broken in entire body, on second day woke up with red rash on face and no where else and on day 3 of diarrhea, and pulled muscle in shoulder and sore ribs was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rash erythematous, Vomiting projectile
Clinical narrative: On second day woke up with red rash on my face (no where else).; Next morning felt like every bone was broken in entire body; Acheyness started 6 hours after shot; 101 fever for 24 hours; On day 3 of diarrehea, violently threw up for 24 hours (pulled muscle in shoulder and sore ribs); On day 3 of diarrehea, violently threw up for 24 hours; Pulled muscle in shoulder and sore ribs; Pulled muscle in shoulder and sore ribs; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 28Apr2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, polycystic ovarian syndrome (PCOS), allergy to intravenous pyelogram (IVP) dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN); both from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 07Apr2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient previously received azithromycin (Z-PAK) and codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 28Apr2021 at 17:00, 6 hours after shot the patient experienced acheyness. On 29Apr2021, next morning the patient felt like every bone was broken in entire body. On Apr2021, the patient experienced 101 fever for 24 hours, on day 3 of diarrhea, violently threw up for 24 hours (pulled muscle in shoulder and sore ribs). On 30Apr2021, on second day woke up with red rash on my face (no where else). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event 101 (units unspecified) fever for 24 hours was resolved on Apr2021, while that of the event violently threw up for 24 hours was resolved on an unknown date in Apr2021. The clinical outcome of the events achiness started 6 hours after shot, next morning felt like every bone was broken in entire body, on second day woke up with red rash on face and no where else and on day 3 of diarrhea, and pulled muscle in shoulder and sore ribs was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pyrexia
Clinical narrative: Nausea; Lightheaded; Dizziness; Fever; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the right arm on 30Apr2021 at 15:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included syncope vasovagal. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient previously received metronidazole (FLAGYL) and experienced drug allergy. On 01May2021 at 00:00, the patient experienced nausea, lightheaded, dizziness and fever. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, lightheaded, dizziness and fever were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Tremor, Vomiting
Clinical narrative: Day nine after second shot experienced chills; headache; nausea; Puked from 3am-1am every 15-30 min; Around 2 PM "my" arms started vibrating. It was a very strong sensation, "I" put my arms up and rotated in effort to release; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 08:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 10:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. On 01May2021 at 03:00, day nine after second shot, the patient experienced chills, headache, nausea, puked from 3:00 to 1:00 (as reported) every 15-30 minutes, could only find relief in a hot bathtub, around 14:00 her arms started vibrating. It was a very strong sensation, she put her arms up and rotated in effort to release. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, headache, nausea, puked, arms started vibrating was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Diarrhoea, Pain assessment
Clinical narrative: Stomach discomfort/ pain; Stomach discomfort/ pain; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 21Apr2021 at 09:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included famotidine (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and fluticasone (MANUFACTURER UNKNOWN); all for unknown indications, from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 24Mar2021 at 09:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021, about a week after the second dose, the patient experienced stomach discomfort, stomach pain and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 28Apr2021, the patient underwent lab tests and procedures included pain scale and the result was 7/10 (Pain is 7/10). Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events stomach discomfort, stomach pain and diarrhea were not recovered at the time of this report.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: "I" have been getting consistent headaches that "I" have never experienced before.; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration on 02Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. On 03Apr2021, after getting the second dose of the Pfizer vaccine the patient had been getting consistent headaches that she had never experienced before. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event consistent headaches was unknown at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Having a fever of 101 towards the end of second day; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date at the age of 26-years-old and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01May2021 at 15:15 at the age of 26-years-old as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. On an unknown date, towards the end of second day the patient had fever of 101. On an unknown date, the patient underwent body temperature test and the result was 101 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever was unknown at the time of this report.    No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Chills; Low fever; Joint pains; Muscle aches; Mild nausea; Fatigue; Injection site pain; headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 30Apr2021 at 16:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included colecalciferol (VITAMIN D3) and multi vitamin GUMMY; both for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 05:00, the patient experienced chills, low fever, joint pains, muscle aches, headaches, mild nausea, fatigue and injection site pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, low fever, joint pains, muscle aches, headaches, mild nausea, fatigue and injection site pain were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Chills; Low fever; Joint pains; Muscle aches; Mild nausea; Fatigue; Injection site pain; headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 30Apr2021 at 16:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included colecalciferol (VITAMIN D3) and multi vitamin GUMMY; both for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 05:00, the patient experienced chills, low fever, joint pains, muscle aches, headaches, mild nausea, fatigue and injection site pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, low fever, joint pains, muscle aches, headaches, mild nausea, fatigue and injection site pain were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Ear discomfort, Ear pain, Insomnia, Pain in extremity
Clinical narrative: lost his sense of taste; My right ear is hurting and partially blocked; My right ear is hurting and partially blocked/right ear hurts; couldn't sleep; sore arm; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 55-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0173; Expiration Date: 31Aug2021), via an unspecified route of administration, on 04May2021 15:00 at the age of 55-year-old, in Arm Left, as dose 1, single for COVID-19 immunization. Medical history included ongoing High Blood Pressure Diagnosed 9 years ago, ongoing Right sided weakness started 9 years ago, aortic dissection from an unknown date and unknown if ongoing started 9 years ago, ongoing Uses cane or walker to walk started 9 years age. Concomitant medication included LOSARTAN taken for hypertension, start and stop date were not reported and patient reported that had been taking this for 9 years and ongoing, ATORVASTATIN taken for an unspecified indication, start and stop date were not reported, ASPIRIN taken for anticoagulant therapy, start and stop date were not reported patient reported that had been taking this for about 7 years also ongoing. Patient known allergies reported as no. Patient did not received any other vaccine within 4 weeks prior to covid vaccine. Patient had not been diagnosed with covid-19 prior and post vaccination. Patient reported that after vaccination on Tuesday night, 04May2021, the right ear was hurting like crazy. Patient couldn't sleep from the pain and almost called 9-1-1. Patient stated that on a scale of 1-10 the pain was an 8 or 9. Patient did not know what to do about this. Patient reported that the pain level fluctuates. The ear pain between a 5 up to a 9 on a pain scale of 1-10. The pain fluctuated but it is constant all day. Patient was clarified his ear started hurting about 17:00. When probed for the outcome of his right ear hurting, patient was explained the pain is going on and off, on and off. On a scale of 1 to 10 with 10 being highest, the pain is about a 9 and goes from 7 to 5 and then goes back to 7 and then back to 8 or 9, just like that the whole day. Patient noticed that lost his sense of taste today, 07May2021 at 12:00 noon. Patient said he's not sure how his smell goes. When probed for details he said his sense of smell is fine. Patient stated that he almost called 911 but he was worried about his family so he didn't call and he endured the pain. Treatment was not received as a result of AE. Patient was not hospitalized, not went to emergency room, no physician visit. The clinical outcome of the event sore arm was recovered in May2021, and all events were not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: headache; nausea; really tired; had fever for a little bit; This is a spontaneous report from a contactable consumer (patient) reported for herself.  A 20-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route at left arm on 09Apr2021 at 10:00 am (lot number: EN6202) (age at vaccination 20-year-old) as dose 2, single for COVID-19 immunisation. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unknown route at left arm on 22Mar2021 at 09:00 am (lot number: EN6208) as dose 1, single for COVID-19 immunisation which was a defective dose. she did not get symptoms after the 1st dose of the vaccine. The patient medical history was reported as none and concomitant medication was not reported. History of all previous immunization with the Pfizer vaccine considered as suspect and additional Vaccines Administered on Same Date of the Pfizer Suspect: None. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had testing for COVID19 regularly and has not had covid19 and every test she has taken is negative for covid19. The patient had a headache, nausea, and was really tired and had fever for a little bit; states the symptoms started the night of 09Apr2021. The adverse events did not required to visit ER or MD office. She has not required treatment for the reported events. 24 hours later after the symptoms started and resolved the night of 10Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Pain
Clinical narrative: Body aches; Migrating joint pain; Significant swelling of the lymph nodes in left arm pit; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 28Apr2021 at 08:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included an unspecified birth control pill on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 07Apr2021 at 08:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 18:00, the patient experienced body aches, migrating joint pain and significant swelling of the lymph nodes in left arm pit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, migrating joint pain and significant swelling of the lymph nodes in left arm pit were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Vomiting
Clinical narrative: Extreme fatigue; Nausea; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 08:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 at 20:00, the patient experienced extreme fatigue, nausea and vomiting. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme fatigue, nausea and vomiting was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Eating disorder
Clinical narrative: Extreme diarrhea on second day, eating nothing and still having liquid feces; Extreme diarrhea on second day, eating nothing and still having liquid feces; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Apr2021 at 22:00, on second day of vaccination, the patient experienced extreme diarrhea, the patient was eating nothing and was still having liquid feces. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event's extreme diarrhea on second day, eating nothing and still having liquid feces was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: Severe headache for three days.; Fatigue for three days; Muscle pain for three days; Very sore arm at place of injection and through the shoulder; Very sore arm at place of injection and through the shoulder; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 27Apr2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included brewers' cancer 2018 for which patient completed treatment in 2019. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tamoxifen (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received tramadol (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 24Mar2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 00:00, the patient experienced severe headache for three days, fatigue for three days, muscle pain for three days and very sore arm at place of injection and through the shoulder. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with OTC medication, rest and lidocaine patches (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fatigue and muscle pain were resolved on 01May2021; while that of the very sore arm at place of injection and through the shoulder were resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Decreased appetite, Dizziness
Clinical narrative: Intense chills; Body aches; Muscle soreness; Stiffness; Weakness; Joint pain in lower body; Severe vertigo; Dizziness; Loss of appetite; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 30Apr2021 at 17:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The medical history included obesity, anemia, childhood thyroid disorder, severe childhood bronchitis and recent abortion. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The concomitant medications included sertraline hydrochloride (ZOLOFT) and amfetamine aspartate/amfetamine sulfate/dexamfetamine saccharate/dexamfetamine sulfate (ADDERALL), all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER0734) via an unspecified route of administration in the left arm on 09Apr2021 at 17:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 03:00, the patient experienced intense chills, body aches, muscle soreness, stiffness, weakness, joint pain in lower body, severe vertigo, dizziness and loss of appetite. It was also reported that survey was taken 24 hours after the second shot. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense chills, body aches, muscle soreness, stiffness, weakness, joint pain in lower body, severe vertigo, dizziness and loss of appetite were resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.